A Louisiana federal judge on Friday largely rejected Novo Nordisk's bid to dismiss one of the earliest lawsuits brought against the pharmaceutical company over side effects of its blockbuster drug Ozempic.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
